NASDAQ, S&P 500 FUTURES POP AS NVIDIA GALVANIZES STOCKS

Shares of the AI bellwether surge, top $1,000 for the first time in premarket trading

BCRX Sep 2024 4.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

2.9500

0.0000

(0.00%)

As of 09:55AM EDT. Market open.

Loading interactive chart...

GuruFocus.com
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.com
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.com
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.